前列地尔注射液

生脉注射液联合前列地尔注射液治疗糖尿病周围神经病变临床观察

Clinical Observation of Shengmai Injection Combined with Alprostadil Injection on Diabetes Peripheral Neuropathy

治疗组在给予治疗冠心病药物的基础上加用前列地尔注射液（凯时）10μg加20mL生理盐水静脉注射，1次/d，2周为一疗程；

The routine treatment was used in both groups , alprostadil injection 10 μ g in normal saline 20 mL was added in the treatment group by intravenous injection once a day for two weeks .

ADR发生频率最高的为前列地尔注射液（凯时），占9.02%；

Alprostadil Injection accounted for 9.02 % of the total , the highest .

目的：观察前列地尔注射液（前列地尔脂微球载体靶向制剂）对脑梗死病人血小板P选择素的影响及临床疗效，探讨其治疗脑梗死的作用机制。

Objective : To observe the effect of Alprostadil on the P-selection of platelet and clinical curative effect of Alprostadil in patients with cerebral infarction . To explore the treatment mechanism of it .

方法对确诊的10例脑出血后PTE的患者，给予前列地尔注射液10μg/d静脉滴注，连续14d为1个疗程。

Methods 10 patients with PTE after cerebral hemorrhage were given Lipo-PGE_1 injection 10 μ g / d by intravenous drip . 14d was one course of treatment .

前列地尔注射液对急性心肌梗死患者梗死面积及心功能的影响

Influence of prostaglandin E_1 injection on infarct area and cardiac function in acute myocardial infarction patients

目的本试验旨在观察种市售前列地尔注射液在治疗下肢慢性动脉闭塞症的等效性和安全性。

OBJECTIVE To compare the equivalence and safety between reference preparation and test preparation of alprostadil injection in patients with chronic lower extremity arterial occlusive disease .

目的：研究前列地尔脂微球载体注射液（Lipo-PGE1）对大鼠小肠淤血性损伤的保护作用。

Objective : To study protective effect of Lipo-PGE_1 for injection on intestinal congestion in rats .

目的观察前列地尔脂微球载体注射液（Lipo-PGE1）对慢性重型肝炎患者血清肿瘤坏死因子-α（TNF-α）、白细胞介素-8（IL-8）水平的影响。

Objective To assess the effects of lipo-PGE_1 injection on the serum levels of INF - α and IL-8 in patients with chronic severe hepatitis .

注射用前列地尔与前列地尔注射液治疗早期慢性重型肝炎的比较

Alprostadil for injection vs alprostadil injection in treatment of early chronic severe hepatitis

前列地尔和肾康注射液在治疗慢性肾功能衰竭具有一定的作用，尤其在改善患者临床症状、提高肌酐清除率、降低血肌酐、血尿素氮等方面都具有确认的疗效。

The combination of traditional Chinese medicine and modern medicine plays a certain role in treatment on chronic renal failure , particularly in improving the clinical symptom , increasing creatinine clearance rate , and in reducing blood creatinine and blood urea nitrogen .